🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: open release

Found 2356 matching trials

A Study To Assess The Pharmacokinetics, Safety, And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release Formulation

PHASE1

The purpose of this study is to (1) evaluate the effect of caloric intake o...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2010-04

Trial ID

NCT01080612

Treatments Being Tested

330 mg pregabalin controlled release 330 mg pregabalin controlled release 330 mg pregabalin controlled release 300 mg pregabalin immediate release

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

PHASE3

The primary purpose of the study is to test the efficacy of 2 tablets (twic...

Status

Completed

Location

Site Reference ID/Investigator# 10044

Start Date

2008-09

Trial ID

NCT00763321

Treatments Being Tested

ABT-712 Placebo

Clinical Evaluation of Bioactive Resin Composites Versus Caries Control Technique in Management of Class I Carious Cavities in High Caries Risk Patients: a Randomized Clinical Trial

The aim of the study is to clinically evaluate the performance of S-PRG bas...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2025-04

Trial ID

NCT06797843

Treatments Being Tested

"SPRG-based" Resin Composite : (BEAUTIFIL II, Shofu Inc. Kyoto, Japan).Alkasite based restoration : Cention N provisional Resin modified glass ionomer followed by Nanohybrid composite

Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration

PHASE1

This is a single centre, open-label, randomised, single dose, three-period,...

Status

Completed

Location

Simbec Research Ltd.

Start Date

2017-05-22

Trial ID

NCT03178214

Treatments Being Tested

Infacort

A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder

PHASE3

Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...

Status

Withdrawn

Location

Multiple Locations

Start Date

2025-04-18

Trial ID

NCT06878833

Treatments Being Tested

LYN-005 (risperidone)Placebo for LYN-005 IR Risperidone Placebo for IR Risperidone

A Randomized Controlled Trial to Evaluate the Effect of White Noises and Parental Voices As Protectors Against Noise Damage in a Neonatal Intensive Care Unit

The goal of this Randomized Controlled Trial is to test the efficacy of lis...

Status

Terminated

Location

IRCCS Istituto Giannina Gaslini

Start Date

2024-02-01

Trial ID

NCT06150404

Treatments Being Tested

White Noises and Maternal and/or Paternal voices

Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring

PHASE1

To investigate the pharmacokinetic effect of a vaginally administered antim...

Status

Completed

Location

Multiple Locations

Start Date

2015-09-15

Trial ID

NCT02545452

Treatments Being Tested

Anastrozole / Levonorgestrel (BAY98-7196)Gyno-Daktarin Sobelin vaginal creme Patentex oval Tampon

Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome

PHASE1

The Hepatopulmonary syndrome (HPS) results from intrapulmonary microvascula...

Status

Terminated

Location

University of Alabama at Birmingham

Start Date

2004-06

Trial ID

NCT00593658

Treatments Being Tested

pentoxifylline

A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

PHASE1

PreTerm Labor (prior to 37 weeks gestation) is the largest single cause of ...

Status

Terminated

Location

GSK Investigational Site

Start Date

2007-03

Trial ID

NCT00449709

Treatments Being Tested

GSK221149

A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

PHASE3

A 26 week trial of TransCon hGH, a long-acting growth hormone product, admi...

Status

Completed

Location

University of Alabama

Start Date

2017-11-13

Trial ID

NCT03305016

Treatments Being Tested

TransCon hGH

Previous Next